V. P. Voronina

V. P. Voronina

Auto-generated profile, based on publicly available information

V. P. Voronina

National Medical Research Center for Therapy and Preventive Medicine

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2018 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
NKN. P. Kutishenko
N. P. Kutishenko
MLM. M. Lukyanov
M. M. Lukyanov
АЗА. В. Загребельный
А. В. Загребельный
NDN. A. Dmitrieva
N. A. Dmitrieva
СМС. Ю. Марцевич
С. Ю. Марцевич
Госпитальный регистр больных, перенесших острое нарушение мозгового кровообращения (РЕГИОН): портрет заболевшего и исходы стационарного этапа лечения

31 December 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
OKO. E. Karpov
O. E. Karpov
MLM. M. Lukyanov
M. M. Lukyanov
SMS. Yu. Martsevich
S. Yu. Martsevich
APAndrey Pulin
Andrey Pulin
СМС. Ю. Марцевич
С. Ю. Марцевич
Проспективный госпитальный регистр больных с предполагаемыми или подтвержденными коронавирусной инфекцией COVID-19 и внебольничной пневмонией (ТАРГЕТ-ВИП): характеристика включенных больных и оценка исходов стационарного этапа лечения

1 January 2016 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
SBSergey Boytsov
Sergey Boytsov
SMS. Yu. Martsevich
S. Yu. Martsevich
NKN. P. Kutishenko
N. P. Kutishenko
MLM. M. Loukianov
M. M. Loukianov
AMA. E. Mitichkin
A. E. Mitichkin
ADA. D. Deev
A. D. Deev

11 March 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MLM. M. Lukyanov
M. M. Lukyanov
NKN. P. Kutishenko
N. P. Kutishenko
SMS. Yu. Martsevich
S. Yu. Martsevich
APAndrey Pulin
Andrey Pulin
EAE. Yu. Andreenko
E. Yu. Andreenko
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective registry.Material and methods. Outcomes in the posthospital period were assessed in 827 patients diagnosed with COVID-19 (age, 58,0±14,8 years; men, 51,3%). For periods of 30-60 days, 6 and 12 months after discharge from the hospital, cases of death, nonfatal myocardial infarction (MI) and stroke, hospitalization, acute respiratory viral infections/influenza were assessed. The follow-up period was 13,0±1,5 months.Results. During the follow-up period, 35 (4,2%) patients died, 6 (0,73%) and 4 (0,48%) cases of MI and stroke were registered. In addition, 142 (17%) patients were hospitalized, while 217 (26,2%) patients had acute respiratory viral infections/ influenza. Factors of age and length of intensive care unit stay were significantly associated (p<0,001) with the risk of all-cause death (hazard ratio (HR)=1,085 per 1 year of life and HR=6,98, respectively), with the risk of composite endpoint (death, non-fatal MI and stroke): HR=1,081 per 1 year of life and HP=4,47. Of the 35 deaths, 11 (31%) were within the first 30 days of follow-up, and 19 (54%) — 90 days after discharge from the hospital. A higher probability of hospitalization was associated with older age (odds ratio (OR)=1,038; p<0,001), while a higher probability of acute respiratory viral infections/influenza was associated with younger age (OR=0,976 per 1 year of life; p<0,001) and female sex (OR=1,414; p=0,03).Conclusion. A prospective follow-up of 827 patients in the TARGET-VIP registry revealed that 12-month mortality was 4,2%, while more than half of the deaths (54%) were registered in the first 90 days, including 31% — for the first month after discharge from the hospital. The most common events were hospitalizations (17,0%) and acute respiratory viral infections/influenza (26,2%), while the rarest were myocardial infarction (0,73%) and stroke (0,48%). The key factors associated with 12-month mortality in the post-COVID-19 period were older age and intensive care unit stay during the reference hospitalization. A higher readmission rate during the follow-up period was associated with older age, and the prevalence of acute respiratory viral infections /influenza during the follow-up period was associated with younger patients and female sex.

1 November 2019 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
VVV. P. Voronina
V. P. Voronina
АЗА. В. Загребельный
А. В. Загребельный
YLYulia Lukina
Yulia Lukina
NKN. P. Kutishenko
N. P. Kutishenko
NDN. A. Dmitrieva
N. A. Dmitrieva
СМС. Ю. Марцевич
С. Ю. Марцевич
Особенности течения мозгового инсульта у больных сахарным диабетом по данным регистра РЕГИОН-М

13 July 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
STS. N. Tolpygina
S. N. Tolpygina
MCM. I. Chernysheva
M. I. Chernysheva
AZA. V. Zagrebelny
A. V. Zagrebelny
VVV. P. Voronina
V. P. Voronina
NPN. E. Parsadanyan
N. E. Parsadanyan
Aim. Assess the two-year survival rate of patients who have undergone acute cerebral circulation disorder, depending on their commitment to visiting the district polyclinic before and after discharge from the hospital.Material and methods. The outpatient part of the REGION-M register included 684 patients attached to the Moscow City Polyclinic №64, discharged from the Moscow City Clinical Hospital n.a. F.I. Inozemtsev of from 01.01.2012 to 04.30.2017 with a confirmed diagnosis of acute cerebral circulation disorder (cerebral stroke / transient ischemic attack).Results. Of the entire cohort, 83.2% of patients and 84.2% after hospital discharge attended the clinic during the year before the development of reference acute cerebral circulation disorder. Patients who attended the clinic before and after the reference stroke were older, more likely to have diabetes, comorbid disease and disability. For 22 months of follow-up, mortality was 28.8% (197 out of 684 people). Among those who applied and did not apply to the clinic before the reference acute cerebral circulation disorder, the difference in mortality tended to be reliable (27.4% versus 35.7%, p <0.1), while mortality was almost twice as low among patients who applied to the clinic at least 1 time after discharge (25.7%) than among patients who did not apply after discharge - 45.4%, p<0.0001. When adjusting for sex and age (the relative risk of death for them was 1.009, 95% confidence interval 1.005-1.01 2, p<0.0001 ), the statistical validity of reducing the risk of death was maintained when patients were committed to visiting the clinic after discharge - the relative risk of death 0.366 (95% confidence interval 0.269-0.500, p<0.0001 ).Conclusion. Lower mortality among those who visited the district polyclinic after undergoing stroke confirms the important role of medical observation in the posthospital period. At the same time, there is a reserve in improving the long-term prognosis of the lives of patients who have suffered a cerebral stroke or transient ischemic attack, due to greater coverage of patients with medical supervision in the clinic.